Abstract
It is well established that estrogen deficiency is strongly linked to the development of insulin resistance (IR), but the mechanism is still unclear. Since IR is characterized by a marked reduction in insulin-stimulated PI3 K-mediated activation of Akt in liver and skeletal muscle, we hypothesized that ovariectomized rats (OVX) would exhibit reductions in the expression of proteins in PI3 K signaling pathway, including PI3 K and Akt. As hypothesized, after observing for 12 weeks, compared with the SHAM rats, ovariectomy led to decreased plasma estrogen level and increased HOMA-IR index; in addition, ovariectomy also caused decreased PI3 K and Akt expression levels in the liver and skeletal muscle. Interestingly, the expression patterns differed in tissue-dependent fashion: Akt1 was only found reduction in liver, whereas Akt2 decreased in muscle; these changes can be reversed by estrogen supplement (OVXE). In conclusion, data demonstrate that estrogen withdrawals may cause IR at least in part by impaired PI3 K/Akt signaling proteins in liver and skeletal muscle, and Akt1 and Akt2 might be tissue-specific expressions.
Similar content being viewed by others
References
M. Prasannarong, K. Vichaiwong, V. Saengsirisuwan, Calorie restriction prevents the development of insulin resistance and impaired insulin signaling in skeletal muscle of ovariectomized rats. Biochim. Biophys. Acta 1822, 1051–1061 (2012)
D. Unal, S. Aksak, Z. Halici, O. Sengul, B. Polat, B. Unal, M. Halici, Effects of diabetes mellitus on the rat liver during the postmenopausal period. J. Mol. Histol. 42, 273–287 (2011)
A. Alonso, R. Fernández, M. Moreno, P. Ordóñez, H. González-Pardo, N.M. Conejo, F. Díaz, C. González, Positive effects of 17beta-estradiol on insulin sensitivity in aged ovariectomized female rats. J. Gerontol. A 61, 419–426 (2006)
A. Alonso, M. Moreno, P. Ordóñez, R. Fernández, C. Pérez, F. Díaz, A. Navarro, J. Tolivia, C. González, Chronic estradiol treatment improves brain homeostasis during aging in female rats. Endocrinology 149, 57–72 (2008)
M.H. Faulds, C. Zhao, K. Dahlman-Wright, J.Å. Gustafsson, The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J. Endocrinol. 212, 3–12 (2012)
X. Yang, Y.Z. Li, Z. Mao, P. Gu, M. Shang, Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats. Chin. Med. J. (Engl) 122, 381–385 (2009)
D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)
R.A. Soslow, A.J. Dannenberg, D. Rush, B.M. Woerner, K.N. Khan, J. Masferrer, A.T. Koki, COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89, 2637–2645 (2000)
M.C. Carr, The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88, 2404–2411 (2003)
R.R. Kalyani, M, Franco, A.S. Dobs, P. Ouyang, D. Vaidya, A. Bertoni, S.M. Gapstur, S.H. Golden, The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J. Clin. Endocrinol. Metab. 94, 4127–4135 (2009)
L.X. Cubeddu, I.S. Hoffmann, Impact of traits of metabolic syndrome on β-Cell function and insulin resistance in normal fasting, normal glucose tolerant subjects. Metab. Syndr. Relat. Disord. 10, 344–350 (2012)
S.R. Salpeter, J.M. Walsh, T.M. Ormiston, E. Greyber, N.S. Buckley, E.E. Salpeter, Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes. Obes. Metab. 8, 538–554 (2006)
V. Saengsirisuwan, S. Pongseeda, M. Prasannarong, K. Vichaiwong, C. Toskulkao, Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 58, 38–47 (2009)
A. Tchernov, J. Calles-Escandon, C.K. Sites, E.T. Poehlman, Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron. Artery Dis. 9, 503–511 (1998)
Y.K. Cao, S.F. Zhang, S.E. Zou, X. Xia, Daidzein improves insulin resistance in ovariectomized rats. Climacteric (2012). doi:10.3109/13697137.2012.664831. PMID: 22607577
M. Prasannarong, V. Saengsirisuwan, P. Piyachaturawat, A. Suksamrarn, Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb. BMC Complement Altern. Med. 12, 28 (2012). doi:10.1186/1472-6882-12-28
American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(suppl 1), S62–S69 (2011). doi:10.2337/dc11-s062
J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, G. Li, L.A. Jelicks, M.F. Mehler, D.Y. Hui, Y. Deshaies, G.I. Shulman, G.J. Schwartz, P.E. Scherer, Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621–2637 (2007)
A.R. Martins, R.T. Nachbar, R. Gorjao, M.A. Vinolo, W.T. Festuccia, R.H. Lambertucci, M.F. Cury-Boaventura, L.R. Silveira, R. Curi, S.M. Hirabara, Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis. 11, 30 (2012)
S.S. Moon, Y.S. Lee, S.W. Kim, Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42, 423–429 (2012)
B.X. Li, Y. Wang, Y. Liu, J.X. Ma, Y.K. Li, Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine 43, 136–146 (2013)
J.D. McGarry, Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7–18 (2002)
Q. Liu, S. Bengmark, S. Qu, The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 9, 42 (2010). doi:10.1186/1476-511X-9-42
E. Bugianesi, S. Moscatiello, M.F. Ciaravella, G. Marchesini, Insulin resistance in nonalcoholic fatty liver disease. Curr. Pharm. Des. 16, 1941–1951 (2010)
Y. Kamada, S. Kiso, Y. Yoshida, N. Chatani, T. Kizu, M. Hamano, M. Tsubakio, T. Takemura, H. Ezaki, N. Hayashi, T. Takehara, Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G1031–G1043 (2011)
M. Fukui, T. Senmaru, G. Hasegawa, M. Yamazaki, M. Asano, Y. Kagami, A. Ishigami, N. Maruyama, K. Iwasa, J. Kitawaki, Y. Itoh, T. Okanoue, M. Ohta, H. Obayashi, N. Nakamura, 17β-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30. Biochem. Biophys. Res. Commun. 415, 252–257 (2011)
A. Paquette, M. Shinoda, R. Rabasa Lhoret, D. Prud’homme, J.M. Lavoie, Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 58, 182–190 (2007)
V.T. Samuel, Z.X. Liu, X. Qu, B.D. Elder, S. Bilz, D. Befroy, A.J. Romanelli, G.I. Shulman, Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279, 32345–32353 (2004)
V.T. Samuel, Z.X. Liu, A. Wang, S.A. Beddow, J.G. Geisler, M. Kahn, X.M. Zhang, B.P. Monia, S. Bhanot, G.I. Shulman, Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117, 739–745 (2007)
N.A. Syed, R.L. Khandelwal, Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells. Mol. Cell. Biochem. 211, 123–136 (2000)
R.A. Gabbay, C. Sutherland, L. Gnudi, B.B. Kahn, R.M. O’Brien, D.K. Granner, J.S. Flier, Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271, 1890–1897 (1996)
J.W. Han, X.R. Zhan, X.Y. Li, B. Xia, Y.Y. Wang, J. Zhang, B.X. Li, Impaired PI3 K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World J. Gastroenterol. 16, 6111–6118 (2010)
L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, S. Fargion, Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57, 1355–1362 (2008)
H. Cho, J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, E.B. Crenshaw 3rd, K.H. Kaestner, M.S. Bartolomei, G.I. Shulman, M.J. Birnbaum, Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292(5522), 1728–1731 (2001)
N. Musi, L.J. Goodyear, Insulin resistance and improvements in signal transduction. Endocrine 29, 73–80 (2006)
K. Cusi, K. Maezono, A. Osman, M. Pendergrass, M.E. Patti, T. Pratipanawatr, R.A. DeFronzo, C.R. Kahn, L.J. Mandarino, Insulin resistance differentially affects the PI 3-kinase and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105, 311–320 (2000)
P. Galluzzo, C. Rastelli, P. Bulzomi, F. Acconcia, V. Pallottini, M. Marino, 17beta-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals. Am. J. Physiol. Cell Physiol. 297, C1249–C1262 (2009)
R.P. Barros, U.F. Machado, M. Warner, J.Å. Gustafsson, Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc. Natl. Acad. Sci. USA 103, 1605–1608 (2006)
M. Moreno, P. Ordoñez, A. Alonso, F. Díaz, J. Tolivia, C. González, Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging. Age (Dordr) 32, 1–13 (2010)
N.H. Rogers, C.A. Witczak, M.F. Hirshman, L.J. Goodyear, A.S. Greenberg, Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem. Biophys. Res. Commun. 382, 646–650 (2009)
E. Riant, A. Waget, H. Cogo, J.F. Arnal, R. Burcelin, P. Gourdy, Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150, 2109–2117 (2009)
Acknowledgments
This study was financially supported by the Hebei Natural Science Foundation (C2009001179) and the Medical Scientific Research Key Program of Hebei Province (20120101).
Conflict of interest
None of the authors has any conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Y., Li, B., Zhang, W. et al. Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats. Endocrine 44, 659–665 (2013). https://doi.org/10.1007/s12020-013-9894-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9894-1